Physicians are uniquely qualified to judge the potential of new medical technologies and can offer tremendous value to their development process. However, as individual investors in medical start-ups the physician’s voice and added value can be lost in the midst of larger financial investors.

+ + +


NTI brings these physicians together and allows them to invest as a group, maximizing the value they bring to the companies and in turn NTI as a whole.  NTI is structured to allow physicians to capture that value for the company and themselves by investing as a group without the high fees or loss of control of their investment associated with a traditional 'fund' model.


These investments have been closed. For current investment opportunities, please log in or contact us.

  • All
  • Closed
Serenity Medical is developing novel neurovascular therapies.
Endostream is developing novel neurovascular therapies.